BioCryst Pharmaceuticals BCRX Occupancy and equipment
Occupancy and equipment at other companies
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseExpense.
The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioCryst Pharmaceuticals's occupancy and equipment.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioCryst Pharmaceuticals's occupancy and equipment?
- BioCryst Pharmaceuticals (BCRX) reported occupancy and equipment of $706K in Q1 2026.
- How has BioCryst Pharmaceuticals's occupancy and equipment changed year-over-year?
- BioCryst Pharmaceuticals's occupancy and equipment increased by 29.8% year-over-year, from $544K to $706K.
- What is the long-term trend for BioCryst Pharmaceuticals's occupancy and equipment?
- Over 3 years (2021 to 2025), BioCryst Pharmaceuticals's occupancy and equipment has grown at a 6.5% compound annual growth rate (CAGR), from $1.66M to $2.01M.
- What does occupancy and equipment mean?
- Costs for office and branch facilities (rent, utilities, maintenance) and equipment (depreciation, repairs, technology hardware) used in operations.